HopeStage
Back to all studies
CompletedNCT01514630

Creatine for Depression in Women Using Methamphetamine

About this titleRead the official source — NCT01514630

Researchers studied Creatine monohydrate to find out how it affected depression symptoms in people with depression.

Medication studyAges 13–64United States
The study in practice

Understand this study

What did researchers investigate?

Researchers studied Creatine monohydrate to find out how it affected depression symptoms in people with depression.

Who was this study for?

Listed age limits: 13 years to 64 years.

Listed locations
Salt Lake CitySee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2013
Recruitment status
Completed
Enrollment listed in the registry
14
Sponsor
Perry Renshaw
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 13 Years to 64 Years
Official registry ID
NCT01514630
Official title
Show the full official title

Creatine as a Treatment Option for Depression in Methamphetamine Using Females

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers studied Creatine monohydrate to find out how it affected depression symptoms in people with depression.

Who is behind this study?

The study sponsor is Perry Renshaw.

Did this study involve medication?

Yes. The study involved medication, including Creatine monohydrate.

Who was this study for?

Listed age limits: 13 years to 64 years.

Want to explore more studies?

Explore studies